PATENT CLAIM ANALYSIS

Application Number: 16008991
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["536", "024500"]

Abstract:
The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.

Claim (Index 20):
The immunotherapy-based viral delivery system of  claim 19 , wherein the at least one helper plasmid comprises first and second helper plasmids, wherein the first help helper plasmid comprises DNA sequences for expressing such proteins derived from the gag and pol genes, and the second helper plasmid comprises a DNA sequence for expressing such protein derived from the rev gene.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 94.0
- Lexical Diversity: 1.15625
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15706481', '15652080', '15849062', '15904131', '15668223']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7612292099507356
- 35 USC 102 Novelty (BERT): 0.6122615258301999
- Combined Prediction Score: 0.7463324415386821
- Mean Citation Score: 655.757314
- Max Citation Score: 760.28394
- Similarity Product: 470.9712345401967

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test